2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity

Bioorg Med Chem Lett. 2007 Oct 1;17(19):5357-60. doi: 10.1016/j.bmcl.2007.08.019. Epub 2007 Aug 15.

Abstract

2-O-carboxymethylpyrogallol derivatives (4-17) were synthesized, with their in vitro inhibitory activities against PTP1B and in vivo antihyperglycemic effects examined. Compound 14, the most potent among the series, showed a K(i) value of 1.1 microM against PTP1B, 7-fold lower than that against TC-PTP. When compound 14 was fed to a high-fat diet-induced diabetic mouse model, significant improvements were observed in both the fasting glucose level and glucose tolerance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Cell Membrane Permeability / drug effects
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dietary Fats
  • Glucose Tolerance Test
  • Hyperglycemia / drug therapy*
  • Hypoglycemic Agents / chemical synthesis*
  • Hypoglycemic Agents / pharmacology*
  • Insulin Resistance
  • Kinetics
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Protein Tyrosine Phosphatases / antagonists & inhibitors
  • Structure-Activity Relationship

Substances

  • Blood Glucose
  • Dietary Fats
  • Hypoglycemic Agents
  • Protein Tyrosine Phosphatases